A Framework for Sequencing Therapy in Grade II IDH-Mutant Gliomas
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Mathematical Modeling and Mutational Analysis Reveal Optimal Therapy to Prevent Malignant Transformation in Grade II IDH-Mutant Gliomas
Cancer Res 2021 Sep 15;81(18)4861-4873, K Aoki, H Suzuki, T Yamamoto, KN Yamamoto, S Maeda, Y Okuno, M Ranjit, K Motomura, F Ohka, K Tanahashi, M Hirano, T Nishikawa, H Shimizu, Y Kitano, J Yamaguchi, S Yamazaki, H Nakamura, M Takahashi, Y Narita, M Nakada, S Deguchi, M Mizoguchi, Y Momii, Y Muragaki, T Abe, J Akimoto, T Wakabayashi, R Saito, S Ogawa, H Haeno, A NatsumeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.